Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a …

J Endrikat, M Cronin, C Gerlinger, A Ruebig, W Schmidt… - Contraception, 2001 - Elsevier
This prospective, open, randomized study was conducted to compare the contraceptive
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg …

J Endrikat, M Cronin, C Gerlinger, A Ruebig, W Schmidt… - Contraception, 2001 - Elsevier
This prospective, double-blind, randomized study was conducted to compare the
contraceptive reliability, cycle control, and tolerability of a 23-day versus a 21-day oral …

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

J Endrikat, B Düsterberg, A Ruebig, C Gerlinger… - Contraception, 1999 - Elsevier
This study compares the contraceptive reliability, cycle control, and tolerability of two oral
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …

A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg …

D Serfaty, ML Vree - The European Journal of Contraception & …, 1998 - Taylor & Francis
Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg …

L Zichella, C Sbrignadello, A Tomassini… - Advances in …, 1999 - Springer
Cycle control and tolerability of two monophasic oral contraceptive pills containing 30 μg
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …

Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.

G Benagiano - International Journal of Fertility, 1989 - europepmc.org
The contraceptive efficacy, cycle control, safety, and subject acceptance of the new
contraceptive (OC) preparations containing gestodene (GTD) plus ethinyl estradiol (EE) are …

Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg

Gestodene Study Group 324 - The European Journal of …, 1999 - Taylor & Francis
Objectives: This multicenter, open-label study was conducted to compare the cycle control,
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …

A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …

S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …

J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …

Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol

Latin American Oral Contraceptive Study Group - Contraception, 1994 - Elsevier
The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …